Review paper
Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies
Volume: 39, Issue: 12, Pages: 4547 - 4554
Published: Jun 13, 2020
Abstract
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease 19 (COVID-19), is a novel human Coronavirus that is responsible for about 300,000 deaths worldwide. To date, there is no confirmed treatment or vaccine prevention strategy against COVID-19. Due to the urgent need for effective treatment, drug repurposing is regarded as the immediate option. Potential drugs can often be identified via in...
Paper Details
Title
Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies
Published Date
Jun 13, 2020
Volume
39
Issue
12
Pages
4547 - 4554